Canadian cannabis producer Organigram Global has announced plans to acquire Germany’s ‘second-largest’ medical cannabis company, Sanity Group, in a deal
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
British American Tobacco [stock_market_widget type=”chart” template=”line” assets=”BATS.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Tobacco giant
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma (formerly
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”JAZZ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The pharmaceutical giant
Canadian cannabis producer Organigram has announced a further major investment from tobacco giant British American Tobacco (BAT). On November 06,
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-based medical cannabis operator Cantourage has
CANTOURAGE has become the third and largest major European medical cannabis operator to go public this year, as investment confidence
LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total funding
THE Kanvas Co. (“Kanvas”), developer of patented electronic vaporizer technology solutions designed to deliver device safety, performance, and reliability for nicotine, cannabis,
Earlier in the year, British American Tobacco (BAT), announced that they secured a nearly 20 percent interest in Canadian cannabis
UK tobacco giant BAT has followed up its £127m investment into Organigram with further investment in a Canadian cannabis company. Research-based Trait
CANNABIS investment company Greencare Capital has appointed Richard Tonthat as CEO just weeks after his work with British American Tobacco
Some of Canada’s largest cannabis companies are losing market share after a tough year, according to data analyzed by ATB
After Moncton-based Organigram announced a subsidiary of British American Tobacco (BAT) was taking a 19.9% stake in the company for
We won’t spam you
